Everest Medicines Revenue and Competitors
Estimated Revenue & Valuation
- Everest Medicines's estimated annual revenue is currently $40.5M per year.
- Everest Medicines's estimated revenue per employee is $251,250
- Everest Medicines's total funding is $310M.
Employee Data
- Everest Medicines has 161 Employees.
- Everest Medicines grew their employee count by -23% last year.
Everest Medicines's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Business Officer | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Chief Medical Officer, Internal Medicine | Reveal Email/Phone |
4 | Head Biometrics | Reveal Email/Phone |
5 | Senior Director, Search and Evaluation | Reveal Email/Phone |
6 | Senior Director, Immunooncology | Reveal Email/Phone |
7 | President and Chief Financial Officer | Reveal Email/Phone |
8 | Chief Medical Officer, Infectious Disease | Reveal Email/Phone |
9 | Chief Technology Officer | Reveal Email/Phone |
10 | Director Business Development | Reveal Email/Phone |
Everest Medicines Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.3M | 61 | 7% | N/A | N/A |
#2 | $354.3M | 461 | -2% | $567.1M | N/A |
#3 | $377.1M | 1876 | -1% | N/A | N/A |
#4 | $7.8M | 39 | 8% | N/A | N/A |
#5 | $5.4M | 27 | 0% | N/A | N/A |
#6 | $45M | 224 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -82% | N/A | N/A |
#8 | $9.2M | 46 | 12% | N/A | N/A |
#9 | N/A | 694 | 46% | N/A | N/A |
#10 | $15.5M | 77 | 5% | N/A | N/A |
What Is Everest Medicines?
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in Greater China and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in China and with leading global pharmaceutical companies. The company's Series A round was led by C-Bridge Capital, a top-tier China healthcare private equity firm, with US $800 million under management.
keywords:N/A
$310M
Total Funding
161
Number of Employees
$40.5M
Revenue (est)
-23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Everest Medicines News
Everest Medicines has signed a memorandum of understanding (MoU) for a collaboration with China Resources Pharmaceutical Group (CR Pharma)...
Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address...
Everest Medicines is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address...
SHANGHAI, Nov. 23, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asia, today announced that ...
SHANGHAI, Nov. 7, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asia, today announced that i ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $21.3M | 161 | 4% | N/A |
#2 | $44.3M | 161 | 3% | N/A |
#3 | $41.4M | 161 | 5% | N/A |
#4 | $23M | 161 | -2% | N/A |
#5 | $15M | 161 | 24% | N/A |